Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Emma Murphy

Assay Development and Screening Team Leader

Emma received her PhD in Biochemistry from the University of Leicester where she studied the function and mechanism of heme peroxidases and the engineered introduction of novel catalytic activities. Emma continued working on biophysical characterisation of peroxidases as a postdoctoral researcher at University College London before moving to the University of Colorado. Here Emma used a combination of high-throughput in silico and medium-throughput biophysical screening to discover novel compounds that bind to and disrupt the normal functioning of mosquito odorant binding proteins. Emma joined the ODDI in 2015 as an assay development and screening scientist and since 2018 Emma has led the assay development and screening team who develop and run biochemical and biophysical high-throughput screening assays. The team aims to identify chemical matter as tool compounds to validate novel neurodegeneration targets and as potential leads for therapeutic intervention.